文献速递腹部MR

磁共振成像作为无创评估胰腺纤维化的方法(MINIMAP):慢性胰腺炎、糖尿病与胰腺癌研究联盟的综合研究设计

Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

MINIMAP研究由美国国立卫生研究院于2018年9月资助,为多机构综合定量磁共振成像研究,在表型明确的慢性胰腺炎患者队列中评估T1弛豫测量、细胞外容积分数、弥散加权成像ADC、磁共振弹性成像、T1加权信号强度比等定量MRI/MRCP特征作为无创影像生物标志物检测和分级慢性胰腺炎的价值,并尝试构建多参数胰腺组织纤维化评分系统。

要点

  • 定量MRI技术如T1 mapping、ECV、DWI-ADC、MRE、T1加权SIR在慢性胰腺炎诊断和严重程度分级中显示前景。
  • 放射科医生目前仍使用仅基于传统胰管成像的Cambridge分级,亟需纳入胰腺实质和胰管特征的新的MRI/MRCP诊断标准。
  • MINIMAP研究旨在评估多种定量MRI/MRCP特征并构建多参数胰腺组织纤维化评分系统。

核心结论

  • 定量MRI/MRCP特征可作为检测和分级慢性胰腺炎的有价值无创影像生物标志物,多参数定量评分系统可能作为胰腺纤维化的生物标志物,用于临床实践和临床试验评估延缓或逆转慢性胰腺炎的药物疗效。

研究设计与样本

  • MINIMAP研究为美国国立卫生研究院于2018年9月资助的多机构综合定量磁共振成像研究,在表型明确的慢性胰腺炎患者队列中进行。

临床应用与阅片要点

  • 放射科医生目前仍使用仅基于传统胰管成像的Cambridge分类,该分类未纳入MRI/MRCP所见的胰腺实质特征。
  • MINIMAP研究将评估T1弛豫测量、细胞外容积分数、T1加权梯度回波信号强度比、磁共振弹性成像、动静脉强化比、表观弥散系数、胰腺体积/萎缩、胰腺脂肪分数、胰管特征及促胰液素刺激后胰腺外分泌输出在慢性胰腺炎评估中的作用。
  • 研究将尝试生成多参数胰腺组织纤维化评分系统,该定量评分系统可能作为胰腺纤维化的生物标志物用于临床实践和临床试验。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Characteristic features of chronic pancreatitis (CP) may be absent on standard imaging studies. Quantitative Magnetic Resonance Imaging (MRI) techniques such as T1 mapping, extracellular volume (ECV) fraction, diffusion-weighted imaging (DWI) with apparent diffusion coefficient map (ADC), MR elastography (MRE), and T1-weighted signal intensity ratio (SIR) have shown promise for the diagnosis and grading severity of CP. However, radiologists still use the Cambridge classification which is based on traditional ductal imaging alone. There is an urgent need to develop new diagnostic criteria that incorporate both parenchymal and ductal features of CP seen by MRI/MRCP. Designed to fulfill this clinical need, we present the MINIMAP study, which was funded in September 2018 by the National Institutes of Health. This is a comprehensive quantitative MR imaging study which will be performed at multiple institutions in well-phenotyped CP patient cohorts. We hypothesize that quantitative MRI/MRCP features can serve as valuable non-invasive imaging biomarkers to detect and grade CP. We will evaluate the role of T1 relaxometry, ECV, T1-weighted gradient echo SIR, MRE, arteriovenous enhancement ratio, ADC, pancreas volume/atrophy, pancreatic fat fraction, ductal features, and pancreatic exocrine output following secretin stimulation in the assessment of CP. We will attempt to generate a multi-parametric pancreatic tissue fibrosis (PTF) scoring system. We anticipate that a quantitative scoring system may serve as a biomarker of pancreatic fibrosis; hence this imaging technique can be used in clinical practice as well as clinical trials to evaluate the efficacy of agents which may slow the progression or reverse measures of CP.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Tirkes T, Yadav D, Conwell DL, et al. Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. Abdom Radiol (NY). 2019. PMID: 31089778. doi:10.1007/s00261-019-02049-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。